Back to mobile site

Ladenburg Thalmann Downgrades Myriad Genetics (MYGN) to Sell

October 10, 2016 7:39 AM EDT Send to a Friend
Ladenburg Thalmann downgraded Myriad Genetics (NASDAQ: MYGN) from Neutral ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login